ReviewNature reviews. Cardiology2011
Diagnosis and management of patients with white-coat and masked hypertension.
Review in Nature reviews. Cardiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 91 citations in OpenAlex.
- Life satisfaction and blood pressure: A coordinated analysis of 16 cohorts.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2026Pooled it
- White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.Journal of hypertension · 2017Pooled it
- Masked hypertension in diabetes mellitus: treatment implications for clinical practice.Hypertension (Dallas, Tex. : 1979) · 2013Pooled it
- Effect of physician attire on patient perceptions of empathy in Japan: a quasi-randomized controlled trial in primary care.BMC family practice · 2021Trial
- The pathophysiology of pre-eclampsia.Nature reviews. Nephrology · 2026Review
- Prevalence and associated factors of comorbidities among hypertensive patients in Northwest Ethiopia, 2024.BMC cardiovascular disorders · 2025Article
- Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future Perspectives.Biosensors · 2025Review
- Systolic Blood Pressure Time in Target Range and Cardiovascular Disease and Premature Death.JACC. Asia · 2024Article
- Discrimination and hypertension among a diverse sample of racial and sexual minority men living with HIV: baseline findings of a longitudinal cohort study.Journal of human hypertension · 2024Article
- Comparing blood pressure measurements between sitting in chairs and sitting on the floor.Clinical hypertension · 2024Article
- Continuous cuffless blood pressure monitoring with a wearable ring bioimpedance device.NPJ digital medicine · 2023Article
- Physics-Informed Neural Networks for Modeling Physiological Time Series: A Case Study with Continuous Blood Pressure.Research square · 2023Article
- Factors influencing home blood pressure monitor ownership in a large clinical trial.Journal of human hypertension · 2022Article
- Association between Cardio-Ankle Vascular Index and Masked Uncontrolled Hypertension in Hypertensive Patients: A Cross-Sectional Study.Journal of healthcare engineering · 2022Article
- White-coat hypertension detected during opportunistic blood pressure screening in a dental healthcare setting.Scandinavian journal of primary health care · 2021Observational
- Patterns of hypertension management in France in 2015: The ESTEBAN survey.Journal of clinical hypertension (Greenwich, Conn.) · 2020Article
- Acceptability and psychological impact of out-of-office monitoring to diagnose hypertension: an evaluation of survey data from primary care patients.The British journal of general practice : the journal of the Royal College of General Practitioners · 2019Article
- Article
- Patient experience of home and waiting room blood pressure measurement: a qualitative study of patients with recently diagnosed hypertension.The British journal of general practice : the journal of the Royal College of General Practitioners · 2018Article
- Masked uncontrolled hypertension: Prevalence and predictors.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
White-coat hypertension is characterized by an elevation in clinic blood pressure but normal home or ambulatory blood-pressure values, whereas patients with masked hypertension have normal clinic blood pressure and elevated ambulatory or home blood-pressure load. Both white-coat and masked hypertension are frequent clinical entities that need appropriate recognition and a close diagnostic follow-up. White-coat and masked hypertension seem to be associated with organ damage and increased cardiovascular risk, although not invariably. In addition, patients with masked or white-coat hypertension have an increased risk of abnormalities affecting their glucose and lipid profiles. Therefore, the diagnosis of these conditions should be accurate and include the assessment of cardiovascular as well as of metabolic risk. Once diagnosed, first-line therapeutic interventions should be nonpharmacological and aim at lifestyle changes, but drug treatment can be indicated, particularly when the patient's cardiovascular risk profile is elevated or when target-organ damage is detected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.